from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1708/-

LFCtreatmentdescriptionclass of inhibitor

-0.462

Amikacinug/mL Amikacintranslation

-2.554

Cap5-10ug/mL Capreomycintranslation

-1.386

Rox10-50 ug/mL Roxithromycintranslation

-0.260

SM2-5 ug/mL Streptomycintranslation

-3.170

Tet5-10 ug/mL Tetracyclinetranslation

1.453

Rif0.2-5ug/mL Rifampicintranscription

-0.596

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.832

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.308

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.186

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.297

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.097

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-3.265

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-2.043

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.392

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.461

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.120

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.634

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.893

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.064

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.366

KCN5-20 ug/mL Potassium cyaniderespiration

0.446

NaN30.2-2 mM Sodium aziderespiration

-0.537

Nigericin50 uM Nigericinrespiration

0.174

TRC10-150 ug/mL Triclosanrespiration

-1.074

TRZ10-25 ug/mL Thioridazinerespiration

-0.779

Valinomycin0.5-10 uM Valinomycinrespiration

0.556

ZnSO42 mM ZnSO4respiration

0.134

menadione6-10 ug/mL Menadionerespiration

-0.598

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.105

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.218

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.277

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.355

NRP_1Non-replicating persistence stage 1dosRassociated

0.518

Amp0.2mg/mL AmpicillincellWall

0.042

Cephalexin20-100 ug/mL CephalexincellWall

-0.263

Cerulenin0.32-5 ug/mL CerulenincellWall

1.169

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.598

EMB10-20 ug/mL EthambutolcellWall

0.164

Eta12-40 ug/mL EthionamidecellWall

-0.054

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.031

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.926

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.083

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.412

BZA0.12 mg/mL BenzamidearomaticAmides

1.421

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.451

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.560

H2O24 mM hydrogen peroxideDNAdamaging

-0.135

Levo10 ug/mL LevofloxacinDNAdamaging

0.750

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.616

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.364

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.727

UVUV-irradiationDNAdamaging

-0.721

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.439

Antimycin12.5-50 ug/mL Antimycin A?

0.184

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.436

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.340

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.031

PA8240.2-2 ug/mL PA-824?

-0.029

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.086

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.086

Verapamil50 uM Verapamil?

0.029

mercaptoethanol2 mM 2-Mercaptoethanol?

0.252

methoxatin10-20 ug/mL Methoxatin?